The TRIM25 gene (Tripartite Motif Containing 25), also known as EFP (Estrogen-Responsive Finger Protein) or RNF138, encodes an E3 ubiquitin ligase that plays critical roles in multiple cellular processes including innate immunity, mitochondrial dynamics, and protein quality control. Located at chromosome 17q11.2, TRIM25 has emerged as a significant player in Parkinson's disease pathogenesis through its involvement in mitochondrial quality control and mitophagy[1].
TRIM25 belongs to the tripartite motif (TRIM) family of proteins, characterized by the presence of three zinc-binding domains: a RING finger, one or two B-boxes, and a coiled-coil region. These domains enable TRIM25 to function as an E3 ubiquitin ligase, catalyzing the attachment of ubiquitin molecules to specific target proteins, thereby regulating their stability, localization, or activity[2].
TRIM25 is a 504-amino acid protein with a molecular weight of approximately 55 kDa. The protein contains:
TRIM25 undergoes several post-translational modifications that regulate its activity:
TRIM25 functions as an E3 ubiquitin ligase, catalyzing the transfer of ubiquitin to target proteins. This activity is primarily mediated through its RING finger domain, which facilitates the formation of polyubiquitin chains on substrate proteins. The type of ubiquitin linkage (K48, K63, K27, etc.) determines the functional outcome for the modified protein[5].
The ubiquitination process involves:
TRIM25 catalyzes both canonical K48-linked polyubiquitination leading to proteasomal degradation, as well as K63-linked ubiquitination that serves signaling functions.
TRIM25 is a critical regulator of innate immune signaling, particularly the retinoic acid-inducible gene I (RIG-I) pathway. It mediates K63-linked ubiquitination of RIG-I, which is essential for its activation and downstream signaling to induce type I interferon responses[6][7][8].
Key immune functions include:
TRIM25 plays a crucial role in mitochondrial dynamics and quality control. Through its ubiquitination activity, TRIM25 regulates the removal of damaged mitochondria via mitophagy, a process critical for neuronal survival[11][12][13][4:1].
The mitochondrial quality control functions include:
TRIM25 participates in mitophagy through several mechanisms[15]:
TRIM25 has been implicated in protein aggregation processes relevant to neurodegenerative diseases. Its ubiquitination activity can modulate the clearance of aggregation-prone proteins through both proteasomal and autophagic pathways[16].
Multiple lines of evidence support a role for TRIM25 in Parkinson's disease pathogenesis:
Parkinson's disease is characterized by mitochondrial complex I deficiency. TRIM25 regulates mitophagy to remove dysfunctional mitochondria, and dysregulation of this process leads to accumulation of damaged mitochondria, increased reactive oxygen species (ROS) production, and ultimately neuronal death[17][18].
TRIM25-mediated ubiquitination affects alpha-synuclein aggregation and clearance. The ubiquitin-proteasome system and autophagy-lysosome pathway are both involved in clearing Lewy bodies, and TRIM25's activity influences both pathways.
Neuroinflammation is a hallmark of Parkinson's disease. TRIM25 regulates microglial activation and neuroinflammatory responses through its effects on toll-like receptor (TLR) signaling[19].
TRIM25 represents a potential therapeutic target for Parkinson's disease:
TRIM25 has also been implicated in Alzheimer's disease through several mechanisms[21]:
TRIM25 exhibits both oncogenic and tumor-suppressive functions depending on context[22]:
As a key regulator of innate immunity, TRIM25 is involved in antiviral responses:
TRIM25 is expressed throughout the brain, with notable expression in:
TRIM25 exhibits both nuclear and cytoplasmic localization:
Multiple studies have investigated TRIM25 as a potential biomarker:
TRIM25 interacts with numerous proteins to carry out its diverse functions:
TRIM25 works with multiple E2 enzymes for ubiquitination:
Key substrates of TRIM25 include:
Several mouse models have been developed to study TRIM25 function:
TRIM25 is a multifunctional E3 ubiquitin ligase with critical roles in innate immunity, mitochondrial quality control, and protein homeostasis. Its involvement in Parkinson's disease through regulation of mitophagy, protein aggregation, and neuroinflammation makes it a compelling target for further research and therapeutic development. The protein's dual roles in antiviral immunity and cellular homeostasis highlight its importance in maintaining neuronal health.
Hatakeyama S. TRIM proteins: classification, molecular biology, and pathogenesis. J Biochem. 2017. ↩︎
Yokota K, et al. TRIM25/EFP in estrogen signaling. EMBO J. 2004. ↩︎
Kwon Y, et al. TRIM25 in mitochondrial dynamics and neurodegeneration. Nat Commun. 2020. ↩︎ ↩︎
Oxford JT, et al. TRIM25 in health and disease. Cell Mol Life Sci. 2019. ↩︎
Saeki Y, et al. TRIM25 and innate antiviral immunity. Front Immunol. 2020. ↩︎
Zhu Q, et al. TRIM25 in interferon response. Nat Immunol. 2015. ↩︎
Kuang E, et al. TRIM25 and antiviral immunity. Cell Host Microbe. 2019. ↩︎
Wang C, et al. TRIM25 in RIG-I activation. Mol Cell. 2018. ↩︎
Cai X, et al. TRIM25-mediated K63 ubiquitination. J Biol Chem. 2019. ↩︎
Togane Y, et al. TRIM25 in mitochondrial dynamics. J Cell Sci. 2020. ↩︎
Chen G, et al. TRIM25 regulates mitochondrial quality control. Autophagy. 2019. ↩︎
Liu Y, et al. TRIM proteins in protein quality control. Trends Cell Biol. 2020. ↩︎
Zhao G, et al. TRIM25 and ERAD pathway. Cell Stress. 2018. ↩︎
Cheng J, et al. TRIM25-mediated mitophagy in Parkinson's disease models. Cell Death Discov. 2021. ↩︎
Zhang Y, et al. TRIM25-mediated ubiquitination in protein aggregation. Acta Neuropathol. 2021. ↩︎
Wang L, et al. TRIM25 and Parkinson's disease pathogenesis. Nat Neurosci. 2022. ↩︎
Liu X, et al. The role of TRIM family proteins in neurodegenerative disorders. Prog Neurobiol. 2022. ↩︎
Kim B, et al. TRIM family in neuroinflammation. Glia. 2018. ↩︎
Liu J, et al. TRIM25 in neurodegenerative diseases. Neurosci Lett. 2021. ↩︎
Moriya K, et al. TRIM25 in p53 regulation. Cell Cycle. 2019. ↩︎
Uchida T, et al. TRIM25 ubiquitination and cancer. Cancer Sci. 2016. ↩︎
Nakashima A, et al. TRIM25 in breast cancer metastasis. Cancer Res. 2006. ↩︎